{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:57:16Z","timestamp":1792526236789,"version":"4.5.0"},"reference-count":23,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,11,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Partially HLA-matched third-party CMV-specific T cells provide long-term viral control in HSCT patients with resistant CMV infection. Viral control occurs in the setting of recovery of CD8+ terminally differentiated effector T cells.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017010223","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T04:25:00Z","timestamp":1570681500000},"page":"2193-2205","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":132,"title":["Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells"],"prefix":"10.1182","volume":"1","author":[{"given":"Barbara","family":"Withers","sequence":"first","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Blood and Bone Marrow Transplant Unit,"},{"name":"Department of Haematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-7139","authenticated-orcid":false,"given":"Emily","family":"Blyth","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Blood and Bone Marrow Transplant Unit,"},{"name":"Department of Haematology, and"},{"name":"Sydney Cellular Therapies Laboratory, Westmead Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leighton E.","family":"Clancy","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Sydney Cellular Therapies Laboratory, Westmead Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Haematology, Royal Adelaide Hospital, SA Pathology, Adelaide, SA, Australia;"},{"name":"School of Medicine, University of Adelaide, Adelaide, SA, Australia;"},{"name":"Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Fraser","sequence":"additional","affiliation":[{"name":"Department of Oncology, Lady Cilento Children\u2019s Hospital, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Burgess","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Sydney Cellular Therapies Laboratory, Westmead Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Simms","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Sydney Cellular Therapies Laboratory, Westmead Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Brown","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Sydney Cellular Therapies Laboratory, Westmead Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kliman","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Blood and Bone Marrow Transplant Unit,"},{"name":"Department of Haematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Celine","family":"Dubosq","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Blood and Bone Marrow Transplant Unit,"},{"name":"Department of Haematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bishop","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Blood and Bone Marrow Transplant Unit,"},{"name":"Department of Haematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Sutrave","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Blood and Bone Marrow Transplant Unit,"},{"name":"Department of Haematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Kei Kris","family":"Ma","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Blood and Bone Marrow Transplant Unit,"},{"name":"Department of Haematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Cancer Centre for Children, Children\u2019s Hospital at Westmead, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth P.","family":"Micklethwaite","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Blood and Bone Marrow Transplant Unit,"},{"name":"Department of Haematology, and"},{"name":"Sydney Cellular Therapies Laboratory, Westmead Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5807-1766","authenticated-orcid":false,"given":"David J.","family":"Gottlieb","sequence":"additional","affiliation":[{"name":"Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia;"},{"name":"Blood and Bone Marrow Transplant Unit,"},{"name":"Department of Haematology, and"},{"name":"Sydney Cellular Therapies Laboratory, Westmead Hospital, Sydney, NSW, Australia;"},{"name":"Department of Medicine, Westmead Hospital, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"issue":"6","key":"2019111616493183900_B1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/bmt.2012.221","article-title":"Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients","volume":"48","author":"Hiwarkar","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"2019111616493183900_B2","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2019111616493183900_B3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1399-3062.2007.00235.x","article-title":"Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation","volume":"9","author":"Almyroudis","year":"2007","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"2019111616493183900_B4","doi-asserted-by":"crossref","first-page":"289.e1","DOI":"10.1016\/j.cmi.2015.11.006","article-title":"Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status","volume":"22","author":"Servais","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"2019111616493183900_B5","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"},{"issue":"18","key":"2019111616493183900_B6","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2019111616493183900_B7","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/cid\/cis625","article-title":"Rapid salvage treatment with virus-specific T cells for therapy-resistant disease","volume":"55","author":"Uhlin","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2019111616493183900_B8","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2019111616493183900_B9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"issue":"12","key":"2019111616493183900_B10","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1086\/648422","article-title":"Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation","volume":"49","author":"Peggs","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"20","key":"2019111616493183900_B11","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"issue":"26","key":"2019111616493183900_B12","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2019111616493183900_B13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbmt.2013.01.021","article-title":"Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution","volume":"19","author":"Clancy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2019111616493183900_B14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jcyt.2015.07.005","article-title":"Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Ma","year":"2015","journal-title":"Cytotherapy"},{"issue":"1","key":"2019111616493183900_B15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"23","key":"2019111616493183900_B16","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1182\/blood-2010-04-281873","article-title":"Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes","volume":"116","author":"Barker","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111616493183900_B17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.bmt.1705699","article-title":"Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies","volume":"40","author":"\u00d6zdemir","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111616493183900_B18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2019111616493183900_B19","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1128\/JVI.78.11.5535-5545.2004","article-title":"Memory CD8 T-cell differentiation during viral infection","volume":"78","author":"Wherry","year":"2004","journal-title":"J Virol"},{"issue":"6","key":"2019111616493183900_B20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1086\/591185","article-title":"Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"198","author":"Moins-Teisserenc","year":"2008","journal-title":"J Infect Dis"},{"issue":"5","key":"2019111616493183900_B21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1705585","article-title":"Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation","volume":"39","author":"Ganepola","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111616493183900_B22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/blood-2017-01-761346","article-title":"PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD","volume":"130","author":"Haverkos","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2019111616493183900_B23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/bmt.2016.111","article-title":"Fatal GvHD induced by PD-1 inhibitor pembrolizumab in a patient with Hodgkin\u2019s lymphoma","volume":"51","author":"Singh","year":"2016","journal-title":"Bone Marrow Transplant"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/24\/2193\/879209\/advances010223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/24\/2193\/879209\/advances010223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T16:49:47Z","timestamp":1573922987000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/24\/2193\/16239\/Longterm-control-of-recurrent-or-refractory-viral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":23,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,11,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017010223","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]}}}